| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $379.8M | +13.8% |
| R&D Expense | $71.4M | -1.3% |
| SG&A Expense | $107.6M | -13.1% |
| Operating Income | -$30.8M | -175.5% |
| Pre-tax Income | -$21.1M | -139.9% |
| Income Tax | $271K | -12.6% |
| Net Income | -$21.4M | -140.6% |
| EPS (Basic) | -$0.40 | -140.0% |
| EPS (Diluted) | -$0.40 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.4M | -43.0% |
| Short-term Investments | $111.8M | -23.4% |
| Accounts Receivable | $42.6M | -34.0% |
| Inventory | $26.7M | +36.9% |
| Current Assets | $257.1M | -26.9% |
| Total Assets | $413.2M | -15.8% |
| Current Liabilities | $89.8M | +0.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.0M | +10.5% |
| Investing Cash Flow | $2.2M | +546.8% |
| Financing Cash Flow | -$93.4M | -1566.0% |
| -143.0% |
| Total Liabilities |
| $110.1M |
| -2.2% |
| Stockholders' Equity | $303.1M | -19.9% |